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A B S T R A C T   
Aims: The main aim of this systematic literature review was to identify risk factors for development of heel 
pressure ulcers and quantify their effect. 
Background: Pressure ulcers remain one of the key patient safety challenges across all health care settings and 
heels are the second most common site for developing pressure ulcers after the sacrum. 
Design: Quantitative systematic review. 
Methods: Data sources: Electronic databases were searched for studies published between 1809 to March 2020 
using keywords, Medical Subject Headings, and other index terms, as well as combinations of these terms and 
appropriate synonyms. Study eligibility criteria: Previous systematic literature reviews, cohort, case control and 
cross-sectional studies investigating risk factors for developing heel pressure ulcers. Only articles published in 
English were reviewed with no restrictions on date of publication. Participants: patients aged 18 years and above 
in any care setting. Study selection, data extraction, risk of bias and quality assessment were completed by two 
independent reviewers. Disagreements were resolved by discussion. 
Results: Thirteen studies met the eligibility criteria and several potential risk factors were identified. However, 
eligible studies were mainly moderate to low quality except for three high quality studies. 
Conclusions: There is a paucity of high quality evidence to identify risk factors associated with heel pressure ulcer 
development. Immobility, diabetes, vascular disease, impaired nutrition, perfusion issues, mechanical ventila-
tion, surgery, and Braden subscales were identified as potential risk factors for developing heel pressure ulcers 
however, further well-designed studies are required to elucidate these factors. Other risk factors may also exist 
and require further investigation. 
Prospero id: PROSPERO International prospective register of systematic reviews: CRD42017071459.   
1. Introduction 
Pressure ulcers (PUs) remain one of the key patient safety challenges 
across all health care settings alongside falls, urinary tract infections 
(UTIs) in patients with a catheter and new venous thromboembolisms 
(VTEs) [1].They affect mainly those with mobility problems, the acutely 
ill and the elderly. At least 200,000 people in the United Kingdom (UK) 
are estimated to develop a new PU each year. On average, PU treatment 
costs £1.45 million per day [2] and these costs are expected to rise with 
the aging population. 
PUs, also commonly known as bedsores, pressure sores, decubitus or 
pressure injuries, are localised damage to the skin and/or underlying 
soft tissues caused by sustained pressure or shear at the weight bearing, 
bony prominence areas such as buttocks, hips, heels, sacrum, spine and 
elbows, of immobilised individuals (or related to medical devices) [3,4]. 
The skin damage can range from non-blanching redness to the skin 
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(category 1) to complete loss of skin exposing inner structures such as 
bone and tendons (category 4), as per the revised NHS Improvement PU 
classification criteria [4]. As a result, PUs can be very painful, debili-
tating and cause emotional distress to the affected individuals and their 
relations. In older adults, they have been reported to increase average 
hospital length of stay by four days [5,6]. 
Historically, Pus have been attributed to poor quality care and being 
a common complication of some long term conditions [7]. Despite 
growing efforts to reduce PUs, prevalence rates remain as high as 10% in 
the acute setting and remains largely unknown in long term care settings 
[8]. PUs have been reported to disproportionately affect different 
anatomical body sites; heel pressure ulcers (HPUs) remain the second 
most common type of PU after sacral PUs, accounting for at least 20% 
[9]. Numerous studies have investigated risk factors associated with all 
PUs without differentiating anatomical sites [10–12]. Furthermore, 
some of these studies explore risk factors for development of PUs in 
specific patient populations, However their study results continue to 
lack a specific focus on HPUs, as they remain the second most common 
type of PU [13–17]. The existence of evidence suggesting that risk fac-
tors associated with HPU development may be different due to the 
anatomy and anatomical position of the heel in the body [18–20] in-
dicates that current prevention strategies may be insufficient for HPU 
eradication. Overall PU incidence and prevalence rates have barely 
reduced recent years [1,3], possibly because preventative strategies 
including risk assessment tools do not target those areas that remain 
problematic i.e., heels. 
The most recent EPUAP/NPIAP/PPPIA guideline, alongside its PU 
definition, states that besides pressure, friction and shear, there are 
other contributory factors associated with PUs, however their signifi-
cance is yet to be established [8]. Furthermore, in 2013, Coleman and 
colleagues concluded that there was no single risk factor associated with 
PU development in their systematic review; instead a complex mixture 
of factors jointly contribute [21]. For this review, a risk or contributory 
factor is defined as any characteristic that is associated with a negative 
outcome [22] in this case the development of a HPU. As risk factors play 
a fundamental role in the prediction and prevention of HPUs, it is 
therefore vital to understand and identify HPU contributory factors in 
order to maximise patient safety. 
2. The review 
2.1. Aims 
The main aim of this systematic review was to identify risk factors for 
developing HPUs in the adult population and quantify the relationship 
between identified risk factors and HPU development. 
2.1.1. Review questions 
What are the risk factors for developing heel pressure ulcers as 
identified from a systematic review of the current literature? 
What is the overall strength of association between each risk factor 
and the development of heel pressure ulcer based on this systematic 
review? 
What are the heel pressure ulcer incidence and prevalence rates from 
eligible studies (cohort and crossectional studies respectively)? 
3. Methods 
The review followed the PRISMA reporting guidelines for reporting 
systematic reviews and meta-analyses [23]. 
3.1. Inclusion criteria 
Type of studies: the review included all cohort, case control and cross- 
sectional studies investigating risk factors for developing HPUs (grade/ 
category/stage 1–4, Suspected/Deep Tissue Injury (S/DTI) and 
unstageable as defined by the NPUAP et al. (2014) (8) guidelines or 
similar). For the purpose of this review, and to be in line with the new 
[4] PU recommendations, HPU severities are described as categories 
(replacing all previous terminologies i.e., grade or stage). Only studies 
published in English were reviewed with no restrictions on date of 
publication. 
Outcome measures: included the presence or development of HPUs 
(categories as defined by the NPUAP et al. (2014) guidelines or similar) 
and/or identification of a risk factor under investigation. 
Participants: Study populations were defined as adult patients aged 
18 years or above in any care setting (i.e., primary or secondary). 
3.2. Exclusion criteria 
All studies not meeting the eligibility criteria were excluded 
accordingly at different stages as depicted in Fig. 1. 
3.3. Electronic searches 
A systematic literature search was conducted in PUBMED 
(1809–March 2020), EBSCO- MEDLINE (from 1879–March 2020), 
CINHAL (1937–March 2020), Ovid-EMBASE (1947–March 2020), 
Cochrane Library (from 1946–March 2020), NICE/NHS evidence (from 
1880–March 2020), PROQUEST, TRIP databases, Scopus (from 
2004–March 2020) and Web of Science (from 1900–March 2020) using 
keywords, Medical Subject Headings (MeSH), and other index terms, as 
well as combinations of these terms and appropriate synonyms. The 
syntax was designed specifically for each database, guided by the 
Cochrane handbook and also adopted from previously published PU 
systematic literature reviews [21,24,25]. Search terms focused on the 
terms heel, pressure ulcer(s), pressure sore(s), decubitus, pressure 
injury, risk factors, contributory factors, predictors, adult, hospital, 
community, and their synonyms (see Table 4 for examples of database 
search strategies). Reference lists of all included studies were inspected 
for further relevant studies. 
3.4. Selection of studies 
The main reviewer (AD) screened titles and abstracts for relevant 
articles prior to appraising the full texts. Identified articles were 
managed using EndNote X8; reasons for all full text paper screen ex-
clusions were documented. The second reviewer (SJ) independently re- 
inspected all identified titles and abstracts to ensure reliability of se-
lection. Where disputes arose, the full report was reviewed for a detailed 
scrutiny. SJ also reviewed full articles of studies that met the review 
criteria to ensure reliability of selection. Any disagreements were to be 
resolved by discussion, or by attempting to contact the study authors for 
clarification. Both reviewers were in agreement with the screening 
outcome. Clarification was sought from authors of one potential eligible 
study, but as no response was received, the study was therefore 
excluded. 
3.5. Data extraction 
AD and SJ extracted data independently from all included studies 
using a predefined form. Study authors were contacted for missing data 
or clarification were appropriate; Twilley and Jones (2016) study data 
were available for further analysis as part of the review. A third reviewer 
(EP) was available to help resolve any disagreements, however, for this 
review the authors were in agreement and no further clarification was 
required. Data were extracted onto standard, predesigned forms. Study- 
specific aims and objectives - study location, design, population, sample 
size, eligibility criteria, methodology and outcome measures (relative 
risk estimates, mean difference, odds ratio (OR), risk ratio (RR), hazard 
ratio (HR), p-values and confidence intervals (CI)) - as presented by 
study authors were also extracted or calculated by the reviewers. 
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3.6. Assessment of risk of bias and quality assessment of included studies 
Currently there is no standardised method of assessing risk bias for 
systematic reviews of risk factors. Therefore, each eligible study was 
assessed for risk of bias using the assessment framework for ascertaining 
quality in prognostic studies (QUIPS) [26] in conjunction with 
STrengthening the Reporting of Observational studies in Epidemiology 
(STROBE) guidance. STROBE offers guidance on methodological con-
siderations in the analysis and publication of observational studies [27, 
28]. The risk of bias assessment rated the relevant methodological pa-
rameters of studies across six areas: study participation (clear eligibility 
criteria to assess risk of selection bias), attrition (withdrawals and 
dropout rates as appropriate), risk factor measurement (validity and 
reliability of data collection tools used and providing clear definitions or 
descriptions of risk factors), outcome measurement (validity and reli-
ability of outcome measurement with clear definitions), study con-
founders (clearly identified and adjusted for using appropriate 
methods), statistical analysis and reporting (use of correct statistical 
methods, and appropriate model building approaches as appropriate). 
Predesigned risk of bias assessment forms designed following the 
QUIPS tool were utilised and within each of the six domains a range of 
questions were rated based on the adequacy of reporting as either ‘yes’, 
‘partial’, ‘no’ or ‘unsure’. Based on these ratings, each domain was 
consequently assessed for its potential overall risk of bias as being either 
high, medium or low after considering all parameters within each 
domain. Results of the risk of bias assessment were used to provide 
classification of overall study quality. Overall study quality was ach-
ieved by aggregation, and where numbers were equal, the higher bias 
classification was recorded. Studies were therefore classified as ‘high 
quality’ if the overall risk of bias was deemed low, ‘moderate quality’ if 
the risk of bias was deemed moderate and ‘low quality’ if the overall risk 
of bias was deemed high. Risk of bias and quality were assessed by two 
independent reviewers (AD, SJ). To maximise quality, the third reviewer 
(EP) extracted data from five randomly selected articles and also 
reviewed these articles for risk of bias and methodological quality. 
3.7. Data synthesis 
Although a meta-analysis was initially planned, it was not conducted 
due to the clinical and statistical heterogeneity of the eligible studies. As 
a result, the findings are presented in a narrative form including a 
summary of main findings and quality assessment results in the form of 
tables. Risk factors for HPU development were grouped into categories 
as guided by other similar systematic reviews [16,21]. Coding was 
conducted by two independent reviewers (AD, SJ); disagreements were 
resolved by discussion and consensus was achieved. 
4. Results 
4.1. Search outcome 
Of the 3,012 titles and abstracts retrieved, 1,258 were duplicates. 
Based on the review selection criteria, 1,754 abstracts were screened, 
and 35 full texts were retrieved and reviewed. Fig. 1 shows the flowchart 
of this selection. Of the 35 potentially suitable articles, 22 were 
excluded. Reasons for exclusion at full article review were: non-English 
articles (n = 4, two were duplicates), case series (n = 7), theoretical 
study (n = 1), HCPs as study participants (n = 1), conference papers of 
eligible studies/letter to editor (n = 7), HPU classification not following 
the EPUAP criteria (n = 1) and no response from study author clarifying 
study eligibility (n = 1). 
4.2. General study characteristics 
Thirteen studies met the eligibility criteria, which recruited a total of 
9,228 participants with a median age of 73 years (range 41.0–101). 
Three studies reported two separate analyses using different study 
populations within the same paper [29–31]. The main analyses in all 
three studies were aimed at identifying potential HPU risk factors using 
multivariate logistic regression analysis. The second analyses used 
different study populations to clarify and validate the statistical signif-
icance of findings from the main analyses. For the purpose of this review, 
these studies were analysed and reported once. Therefore, a total of 
thirteen studies are reported in this review. Delmore et al. (2015) (30) 
and Delmore et al. (2019) (31) were conducted by the same authors, the 
latter being a replicate study using separate multicentre data and a 
larger sample size. For this review, they are reported as separate studies 
distinguished by the year of publication. Muntlin-Athlin et al. (2016) 
(32) and Manderlier et al. (2019) (33) were secondary analyses of HPU 
risk factors based on data collected from a randomised controlled trial 
(RCT) and a cross-sectional point-prevalence survey, retrospectively 
[33,34]. Table 1 provides further study characteristics of all eligible 
studies. 
Five eligible studies were published in the United States of America 
(USA), two in France and three in the UK, and Canada, the Netherlands 
and Sweden produced one study each. Duncan et al. (2003) (n = 53) 
[35] and Delmore et al. (2015) (n = 417) [30] did not report gender 
distribution amongst their study participants (see Table 1). Edwards 
et al. (2006) (36) reported gender for only 68% of HPU participants and 
none for the control group. For the eleven eligible studies that reported 
gender distribution of study participants, 57.1% (5270/9228)were fe-
male. Tourtual et al. (1997) (29), Demers (2005) (37) and Delmore et al. 
(2019) (31) were the only studies to report ethnicity for their study 
participants: the majority of the were reported as either white-20.5% 
(571/2780), or as other ethnic background 66.4% (1846/2780). 
Median HPU incidence rate was 17.4% (range: 2.9%- to 29.5%) 
based on the incidence rate from the four prospective and two retro-
spective cohort studies [29,32,35–38]. Median prevalence was 11.7% 
(range: 1.5%–20.8%) based on the two cross-sectional studies and two 
retrospective case control cohort studies [30,31,31,33]. Across all 
studies, the participant population was diverse and included: patients 
from hospital wards with high HPU prevalence, a geriatric rehabilitation 
centre, major abdominal surgery, elective or trauma orthopaedic sur-
gery, nursing homes and patients receiving community care. 
All eligible studies defined HPUs based on NPUAP et al. (2014) (8) or 
similar guidelines that were available at the time the studies took place. 
Only three studies did not report the number of HPUs by severity [30,32, 
37]. In total, 10.1% (935/9228) of participants were either recruited 
with or developed a HPU during study follow-up. Of the studies that 
reported HPUs by severity: 38.8% (306/788) were category 1; category 
2–27.4% (216/788) category 3–7.5% (59/788); category 4–5.5% 
(43/788); Unstageable- 18.4% (145/788) and DTI- 2.4% (19/788). Only 
three out of nine studies that reported HPU by severity observed 
unstageable and DTI HPUs; the patient population in these studies were 
heterogeneous [31,33,39]. Tourtual et al. (1997) [29] and Campbell 
et al. (2006) [38] study participants developed superficial HPU (either a 
category 1 or 2), except for one participant from the Tourtual et al. 
(1997) (29) study who developed a category 3 HPU. 
4.3. Quality of studies 
Table 2 provides a summary of the risk of bias and quality assess-
ments. The review only included studies of observational design that 
investigated risk factors for HPUs only; four were prospective cohort 
studies [29,32,35,38], two were retrospective cohort studies [36,37], 
three were cross-sectional studies [33,39,40], two were retrospective 
matched case control cohort studies [30,31], and two were prospective 
matched case control studies [41,42] (see Table 1 for full study 
characteristics). 
Three studies [36,37,39] performed and reported descriptive anal-
ysis results based on participants who had HPUs. Four out of eleven 
(36.4%) studies performed multivariable logistic regression analysis in 
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(no, list of risk factors) 









Tourtual et al 
(1997) 
USA 
Main analysis: n =
209 patients 
Validation analysis: 




part of United 
Health Services 
Hospitals in the 
Broome County 
Metropolitan area 




to units that 
experienced high 
HPU prevalence 
based on their 
previous survey. 
Inclusion criteria: 
All patients who gave 
informed consent and 
were admitted to four 
nursing units 
participating in the study. 







The purpose of this 
research was to 
determine the 














1: 94.6% (53/56) 
2: 5.4% (3/56) 
3:- 
4:- 
Age 0.0001 MD: 13.7 9.7; 17.8 
LOS 0.0001 MD: 12.9 6.8; 18.9 
Height 0.002 MD: 2.1 − 3.4; − 0.8 
Weight Initial 0.0001 MD -26.4 − 40.3; 
− 12.4 
Weight Final 0.04 MD: 18.9 − 36.7; − 1.1 
Albumin Initial 0.0001 MD: 0.4 − 0.6; − 0.2 
Albumin Final 0.002 MD: 0.4 − 0.7; 0.2 
Protein-Initial 0.04 MD: 0.4 − 0.7; − 0.02 
Haemoglobin-(g/L) 
Initial 
0.009 MD: 0.9 − 1.6; − 0.2 
Highest pulse 0.05 MD: 5.9 − 0.005; 
11.9 
No. of diagnosis 0.0001 MD: 3.5 2.5; 4.6 
Admitted with PU 0.005 RR: 2.3 1.4; 3.7 
Incontinence 0.00001 RR: 2.7 1.7; 4.3 
Limb weakness    
Left 0.02 RR: 1.7 1.1; 2.7 
Right 0.07 RR: 1.5 1.0; 2.4 
Both 0.4 RR: 1.6 1.0; 2.6 
Preventative ointment on 
heels on admission 
0.04 RR: 2.0 1.2; 3.4 
Had a diagnosis of 
neoplasm 
0.004 RR: 2.0 1.3; 3.0 
Circulatory problems of 
lower limb 
0.004 RR: 1.0 1.0; 3.2 
CHF 0.01 RR:1.8 1.2, 2.8 
Respiratory disease 0.002 RR: 2.2 1.4; 3.4 
Any 3-consecutive 
worsening of appetite 
0.0004 RR: 2.4 1.4; 3.7 
Nutrition services 
documented 
0.000001 RR: 5.8 2.8; 12.3 
Sheets tightly tucked in 
before development of 
HPU 
0.009 RR: 1.9 1.1; 3.3 
Braden Scale    
Sensory perception 0.0001 MD: 0.4 − 0.6; − 0.2 
Moisture 0.03 MD: 0.2 − 0.4; 0.02 
Activity 0.02 MD: 0.3 − 0.06; 
− 0.05 
Mobility 0.0001 MD: 0.5 − 0.7; − 0.3 
Nutrition 0.03 MD: 0.3 − 0.5; − 0.02 
Friction and shear 0.0001 MD: 0.5 − 0.7, − 0.4 
Total Braden Score 0.0001 MD: 2.3 − 3.2, − 1.4 
Validation Analysis 






Age 0.0001 MD: 7.6 3.8; 11.4 
LOS 0.0001 MD: 8.4 4.5; 12.2 
Admitted with PU 0.02 RR: 2.5 1.4; 4.7 
(continued on next page) 
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developing HPU 
and by Category 
Risk factors investigated 
(no, list of risk factors) 













Mean age: 67.6 
yrs (18.2) 
1: 92% (58/63) 
2: 6.3% (4/63) 






Incontinence (any) 0.0003 RR: 1.3 1.1; 1.5 
Limb weakness-Left, 
Right, Both 
0.03 RR: 1.6 1.0; 2.5 
Pulses (not palpable on 
one or the other 
extremity):    
Popliteal 0.005 RR: 1.9 1.2; 3.1 
Posterior Tibial 0.01 RR: 1.8 1.1; 2.9 
Current diagnosis of 
circulatory problems of 
lower limb 
0.08 RR: 1.5 1.0; 2.3 
Told has a diagnosis of:    
CHF 0.005 RR: 1.9 1.2; 3.0 
Circulatory problems of 
lower limb 
0.06 RR: 1.5 1.0; 2.4 
Braden Scale    
Sensory perception 0.03 MD: 0.2 − 0.4; − 0.03 
Moisture 0.002 MD: 0.3 − 0.5; − 0.1 
Activity 0.0001 MD: 0.5 − 0.8; − 0.3 
Mobility 0.0001 MD: 0.4 − 0.7; − 0.2 
Nutrition not 
significant 
MD: 0.1 − 0.3; 0.1 
Friction and shear 0.0001 MD: 0.4 − 0.6; − 0.2 
Total Braden score 0.0001 MD: 2.2 − 3.1; − 1.3 
Logistic regression results 
Braden moisture 0.00001 Not 
reported 
Not reported 
Braden Friction and 
Shear 
0.01 
Duncan et al 
(2003) 
UK 








Age of 20 years who had 
major abdominal surgery. 
use of epidural as pain 
relief during the peri- 
operative period 






The objective of this 
study was to investigate 
the relationship 
between post-operative 
epidural analgesia and 
incidence of heel 
pressure sores 








1: 72.7% (8/11) 
2: 27.3% (3/11) 
3:- 
4:- 






















Hypotension Not reported Not 
reported 
Edward et al. 
(2006) 
UK 




NHS Trust (tertiary 
Inclusion criteria: 
All patients who had 
undergone a hip and knee 
replacement and 





Highlight the risk of 




Mean age: 74.3 




Cases: 7.8% (50/ 
637) 
Category (*only 
reported for 32/ 
50 HPU) 
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developing HPU 
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Risk factors investigated 
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HPU between August 











PNB (3 in 1) 
Spinal 
Epidural 
Epidural + Sciatic 
Epidural + PNB 
CSE 
















N = 103 
Setting: 
Three 150–250 







Patients aged 18 years or 
older admitted during the 
year 2003 with a primary 
or secondary diagnosis of 
vascular disease indicated 
with ICD-9-CM:443.9 
Exclusion criteria 
Pre-existing heel ulcer, a 
diagnosis of diabetes 
mellitus, incomplete 
medical records, and 
patients admitted for less 
than 24 h. 
Retrospective 























n ¼ 82 patients 
Setting: 3 hospitals 




established heel pressure 
ulcers 
Controls-patients without 
heel pressure ulcer 
matched on age and 










Explore for lower limb 
atherosclerosis with the 
goal of attempting to 
associate the presence 
of blood 









1: 10% (4/40) 
2: 50% (20/40) 
3: 30% (12/40) 








†OR: 2.1 0.8; 5.7 





†OR: 15 1.7; 132.9 
Clegg et al 
(2009) 
USA 
n = 84 patients 
Setting: 8 health 
care system in 








The sample included 
patients 18 years or older, 
who were under the care 
of a participating WOC 
nurse and who 
experienced a HPU 
Exclusion 







The purpose of the 
multisite research 
project was to describe 
the physical 
characteristics and 
medical history of 
patients experiencing 
HPU 







Cases 100% (84) 
Category 
1: 12% (10/84) 
2: 25% (21/84) 
3: 4% (3/84) 
4: 10% (8/84) 
Unstageable: 
31% (26/84) 
SDTI: 19% (16/ 
84) 
Height (in) Mean (SD) N/A 65.7 (5.9) N/A 
Weight (lb) Mean (SD) 164.04 
(47.2) 
BMI Mean (SD) 27.4 (11.3) 
Braden scale score Mean 
(SD) 
13.4 (3.3) 






Pulse oximetry (%) Mean 
(SD) 
96.2 (2.9) 
Blood urea nitrogen(mg/ 





Time in surgery 
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incidence rate % 
developing HPU 
and by Category 
Risk factors investigated 
(no, list of risk factors) 









Palpable pedal pulse, (Y) 
n (%) 
Pedal oedema, (Y) n (%) 22 [26] 
Diabetes, (Y) n (%) 47 (56) 
Smoker, (Y) n (%) 7 [8] 
Vasopressor use, (Y) n 
(%) 
7 [8] 
Corticosteroid use, (Y) n 
(%) 
7(8) 
Systemic infection, (Y) n 
(%) 
24(29) 
End-stage renal Disease, 
(Y) n (%) 
22(26) 
Surgery this admission, 
(Y) n (%) 
7(8) 
History of peripheral 
arterial disease, (Y) n (%) 
33 [40] 
History of venous stasis 
disease, (Y) n (%) 
5(6) 
Campbell et al 
(2010) 
Canada 
n = 150 patients 
Setting: 850 
academic bed, 
tertiary care facility 
London Health 
Centre, University 
Hospital, located in 
a small urban 








treatment of a 
fracture 
Inclusion criteria: 
if they or their substitute 
decision-maker provided 
written informed consent 
to participate in the 
research study; were 
older than 18 years; had 
an orthopaedic condition 
of the pelvis, hip, or lower 
extremity; and were 




excluded if they were 
actively dying or if it was 
impossible to view both 
heels for any reason (e.g. 








1.The incidence of HPU 
in an orthopaedic 
population of an acute 





and medical risk factors 
associated with 
increased risk of 
developing a HPU. 
3. The natural history/ 











Haemoglobin (g/L) mean 
(SD) 
0.9 †MD: 1.7 
(13.4) 
− 28.5; 25.2 
Age (years) 0.6 †MD: 3 (5.8) − 8.6; 14.6 
Pulse (per minutes) mean 
(sd) 
1 †MD: 0 (5.8) − 11.6; 11.6 
HP relief measures used 
(n) 
0.016 †OR: 7.5 0.87; 64.4 
Respiratory disease (n) 0.96 †OR: 1.24 0.13; 11.2 
Altered mental status (n) 0.41 †OR: 0.69 0.15; 3.2 




Haemoglobin (g/L) (SD) 0.01 †MD: 16.2 
(6.0) 
4.3; 28.1 
Age (years) 0.79 †MD: 3 (3.4) − 9.7; 3.7 
Pulse (per minutes) 0.05 †MD:10 
(6.6) 
− 3.0; 23.0 
HP relief measures used 
(n) 
0.55 †OR:0.95 0.1; 9.4 
Respiratory disease (n) 0.011 †OR: 5.8 1.4; 23.9 
Altered mental status (n) 0.029 †OR: 3.9 1.1; 14.0 







2: 19% (4/21) 3: 
4: 
Haemoglobin (g/L) mean 
(SD) 
0.056 †MD: 10 
(6.1) 
− 2.1; 22.1 
Age (years) mean (SD) 0.602 †MD: 1.7 
(3.1) 
− 7.8; 4.5 
Pulse (per minutes) mean 
(SD) 
0.279 †MD: 5 (3.6) − 2.1; 12.1 
HP relief measures used 
(n) 
0.133 †OR: 3.5 1.1; 11.5 
(continued on next page) 
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Eligibility criteria Design and 
analysis method 







incidence rate % 
developing HPU 
and by Category 
Risk factors investigated 
(no, list of risk factors) 









Respiratory disease (n) 0.016 †OR: 1.7 0.6; 4.7 
Altered mental status (n) 0.216 †OR: 0.6 0.2; 1.6 
LOS mean (SD) 0.161 †MD: 3.0 
(2.1) 











admitted to a 
geriatric 
rehabilitation 
centre from March 
2009 to June 2010 
Inclusion criteria: 
Individuals admitted to a 
geriatric rehabilitation 
centre in two French 
university hospitals from 
March 2009 to June 
2010. 
Exclusion criteria: 
Individuals with a MMSE 
score of less than 10 were 
not included. Individuals 
with central or medullar 
nervous system disease 
(hemiplegic and 
paraplegic patients) were 





To identify associated 
factors in older 
hospitalised adults 







rate: 12.4% (26/ 
210) 
Category 
1: 50% (13/26) 
2: 26.9% (7/26) 
3: 15.4% (4/26) 
4: 7.7% (2/26) 
Sensory Peripheral 
Neuropathy (Light vs 
Moderate& Severe) 
0.07 †OR: 3.8 †0.9; 16.6 
NSS 0.009 †MD: 1.3 
(0.5) 
0.3; 2.3 
NDS 0.011 †MD: 3.0 
(1.2) 
0.6; 5.4 
HPU Category and NSS 0.02 r = 0.45 Not reported 
HPU Category and 
activity limitation 
0.02 r = 0.44 
HPU Category and Hip 
fracture, cancer, diabetes 










HPU severity vs 
Neuropathy severity 




Delmore et al 
(2015) 
USA 
Main analysis n =
337 patients 
Validation analysis 
n = 80 patients 








Admitted with HPU or 
developed a HPU 
between 2009 and 2011. 














To develop and 
validate a method of 
predicting whether 
patients will develop a 
heel pressure ulcer 
during their hospital 
stay. 
Main analysis 
Mean: age 73yrs 















HPU severity not 















Braden scale score (mean, 
SD) 
<0.001 
Diabetes (%) 0.03 
Vascular disease <0.001 
Neuropathy 0.03 
Immobility <0.001 
Perfusion issues 0.007 
Morbid obesity 0.3 
Cachexia 0.7 
Surgery > 3h (%) 0.7 
ICU >3 days (%) <0.001 




Diabetes 0.02 OR: 2.9 1.2; 1.7 
Vascular disease 0.01 OR: 3.8 1.3; 11.1 
Immobility 0.003 OR: 4.7 1.7; 12.9 
Braden scale score </ =
18 
<0.001 OR: 21.8 6.3; 76.1 
Muntlin- 
Athlin et al 
(2016) 
Sweden 
n = 183 patients 
Setting: Five 
ambulance 
stations, two EDs 






symptoms or reduced 
general condition 
according to medical 






U test and t-test 
1.Describe heel 
pressure ulcer 
prevalence and nursing 
actions in relation to 
pressure ulcer 
prevention during the 
care delivery chain (i.e. 








rate: 8% (15/ 
183) 








Reaction Level Scale 
Pulse oximetry (%) 
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Eligibility criteria Design and 
analysis method 







incidence rate % 
developing HPU 
and by Category 
Risk factors investigated 
(no, list of risk factors) 









councils in Sweden. 
Population: older 








call centre No heel 
pressure ulcer 
Admitted to one of the 
participating wards 
Able to sign consent form. 
Exclusion criteria: 
patients requiring life- 
threatening support and 
discharged from ED 
Unable to provide signed 
informed consent or did 
not have family member 
to sign. 
pre-hospital and 
emergency care level, 
and further at the 
hospital ward), for 
older patients with 
neurological symptoms 
or reduced general 
condition. 
2.Investigate early 
predictors for the 
development of heel 
pressure ulcer during 









Blood pressure (diastolic) 
mmHg 
due to lack 
of data (n) 
Day 1 
MNS 




Physical activity 0.001 MR: 49.7 vs 
78.0 
Mobility <0.0001 MR:48.6 vs 
78.2 
Incontinence 0.002 MR:51.0 vs 
77.7 














Inpatients aged 18 and 
over with a Category 2, 3 
or 4 pressure ulcers of the 
heel. 
Exclusion criteria: All 
inpatients without a 
pressure ulcer of the heel 
and matching the case 
group based on age, 







1. Explore the 
relationship between 
pressure ulcers of the 
heel and PAD. 




matched case control 
study that could further 
investigate aim [1] 






HPU: 50% (15/ 
30) 
Category: 
2: 33.3% (5/15) 
3: 47.7% (7/15) 
4: 20% (3/15) 
PAD 0.01† OR: 11 2.0: 60.6 
Delmore et al 
2019 
USA 
Main analysis: n =
1.697 patients 
Validation analysis: 
n = 240 





patients aged 18 
years or above 
Inclusion criteria: 
All hospitalised adults 
aged 18 years or above. 
Exclusion criteria: 
Patients with heel 
vascular wounds as 
designated by the 
associated International 
Classification of Disease 
(ICD-9). 
Obstetric and psychiatric 
patients. 









1.To replicate previous 
research that found 
that found four 
independent and 
significant predictors of 
HPUs in hospitalised 
patients using a larger 
and more diverse 
patient population. 
2.To create a clinical 
enabler for assessing 
patients at risk of HPUs. 
Main analysis 






























3: 5.0% (16/323) 











1: 27.5% (22/80) 
2:26.3% (21/80) 
Age> 65years <0.001 OR: 
3.3 
2.4; 4.6 
Diabetes 0.03 OR: 
1.4 
1.0; 1.9 
Vascular disease 0.001 OR: 
3.1 
1.8; 5.2 
Perfusion issues <0.001 OR: 
2.8 
2.1; 3.8 
Impaired nutrition <0.001 OR: 
6.9 
4.1; 11.5 
Mechanical ventilation <0.001 OR: 
7.7 
4.2; 14.3 
Surgery <0.001 OR: 
1.8 
1.3; 2.5 
(continued on next page) 
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Eligibility criteria Design and 
analysis method 







incidence rate % 
developing HPU 
and by Category 
Risk factors investigated 
(no, list of risk factors) 













3: 5.0% (4/80) 









Manderlier et al (2019) 
Netherlands 
n = 4,842 patients 
Setting: nursing homes 
and community care 
facilities across 
Netherlands 




to be 18 years or 
older, reside in a 
















aim of this study 






the presence of 
category I–IV 
PUs on the body 
sites most 
vulnerable to PU 
development, 
the sacrum, and 
heels. 
2.A secondary 
aim of this study 















Prevalence rate: 1.5% 
(75/4,842) 
Category: 1: 50.7% (38/ 
75) 2: 16% (12/75) 3: 
16% (12/75) 4: 1.7% (8/ 
75) Unstageable: 2.7% 
(2/75) DTI: 4% (3/75) 
Category 1–4 
















Not reported OR 0.32 0.17; 0.62 
All variables are reported in the table using the same descriptions as in the original articles, CSE-Combined spinal and epidural; MD- Mean difference; MNS-Modified Norton Scale; PNB-peripheral nerve block OR-odds 
Ratio, †values calculated by review authors. 
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addition to descriptive statistics [29–31,33]. The rest of the eligible 
studies either performed parametric or non-parametric analyses (chi-s-
quared, t-test and Whitney Mann-U tests) or just reported ORs as 
appropriate. Not all studies that reported on measures of association 
included CIs or p-values as appropriate; where adequate data was re-
ported, reviewers attempted to calculate these based on the extracted 
data, as highlighted in Table 1. 
Only three studies ([31,33,42] were classed as high quality, seven 
were of moderate quality [29,30,32,35,38,40,41]and three were of low 
quality [36,37,39] (see Table 2). Two high quality studies [31,42] and 
three moderate quality studies [29,35,38] reported on their sample size 
assumptions and/or calculations. Of the four eligible studies that per-
formed additional multivariable analysis, only Delmore et al. (2019) 
(31) and Manderlier et al. (2019) [33] had sufficient numbers of HPUs 
(events) per risk factor (i.e.10 events per risk factor) in their final logistic 
regression model. 
The main issues contributing to high risk of bias and consequently 
rendering 10/13 studies moderate to low quality: were their retrospec-
tive study design, lack of comparator group, study participants only 
being high risk patients and already experiencing HPUs, lack of sample 
size calculations, selection bias, inadequate reporting and statistical 
analysis issues. All of these issues may have influenced the accuracy of 
the study results, interpretation and generalisability. As a result, the 
evidence from low quality studies could not be utilised to inform the 
decision as to whether to accept or reject these variables as potential risk 
factors for developing HPUs. It was evident from the review that most of 
the eligible papers did not follow the STROBE recommendations. 
STROBE recommendations were developed to facilitate critical 
appraisal, interpretation of results and consequently enable direct 
translation of research into clinical practice [28]. As a result, most of the 
studies were rated as manifesting moderate risk of bias across the six 
subdomains of the QUIPS tool. 
4.4. Risk factors 
In total, 51 different variable names were identified from the 13 
eligible studies. These were categorised into 16 risk factor domains as 
summarised in Table 3. Although some studies used standardised mea-
sures (e.g., validated risk assessment tools), there was still a lack of 
consistency across the tools utilised, measurement scales, or classifica-
tion of diseases investigated. The Braden scale (PU a risk assessment 
tool) was the most used validated measurement scale. All variables 
identified in this review are listed in Table 3 according to the specifi-
cation in each of the eligible studies. Table 3 highlights the heteroge-
neity of variables utilised across different studies. Lack of consistency in 
measuring and reporting of variables made it difficult to synthesise re-
view results using quantitative methods. 
Nine risk factors (body mass index, smoking status, pre-albumin, 
blood urea, creatinine, systemic infection, end-stage renal disease, 
vasopressor and corticosteroid use) were only investigated in one low 
quality study [39].Thirty two other remaining variables were examined 
in at least one or more moderate quality studies [29,32,35,40] as po-
tential contributory factors for HPU development using descriptive and 
univariate analyses. Haemoglobin, respiratory rate and the use of HPU 
preventative measures emerged as significant in one moderate quality 
study [38] which involved patients undergoing either elective ortho-
paedic or hip surgery. 
The MNS subscales: physical activity and incontinence emerged as 
significant in the Muntlin-Athlin et al. (2016) [32] study only however 
this study did not adjust for another potential confounders in their 
analysis. Mental status, although measured differently in the Campbell 
et al. (2010) [38] and Muntlin-Athlin et al. (2016) [32] (moderate 
quality) studies, emerged as significant in both studies. Length of sur-
gery and perioperative analgesia were considered in moderate to low 
quality studies only [30,35,39] and results were either statistically 
insignificant or not reported. 
Sensory neuropathy as defined by the Braden subscale [29] or using 
the neuropathy symptom score (NSS) and neuropathy disability score 
(NDS) [40] were also found to be significant in univariate analysis. Only 
the Braden subscale ‘sensory perception’ item was further considered in 
a multivariable analysis, however did not emerge to be statistically 
significant [29]. Overall, almost all moderate quality studies did not 
adjust for confounding factors (with the exception of [29]. The studies 
were also inconsistent in reporting measures of association, and inade-
quately reported on sample size assumptions, statistical analysis plans, 
p-values, and CIs. All of these factors impacted on the review authors’ 
ability to fully assess the studies’ potential risk of bias and interpretation 
of results. Consequently, there is no conclusive evidence to support 
whether these variables are risk factors for HPU development, given that 
the studies were of moderate quality. 
A total of 10 potential risk factors were examined in at least one high 
quality study [31,33,42] that involved hospital, nursing home, 
community-dwelling, and rehabilitation patients. A disease status of 
either diabetes or lower limb vascular disease emerged as statistically 
significant in more than one high quality study. The Delmore et al. 
(2015) [30] (moderate quality) and Delmore et al. (2019) [31] (high 
quality) studies found that hospital patients with diabetes were at least 
1.4 times (95%CI: 1.0; 7.2) more likely to develop a HPU compared to 
those without diabetes. 
Lower limb vascular disease emerged as statistically significant in 
two high quality studies [31,42] and two moderate quality studies [30, 
41]. Participants diagnosed with lower limb vascular disease were at 
least 3.1 times (95%CI: 1.3; 60.2) more likely to develop a HPU 
compared with those without lower limb vascular disease. There is some 
evidence to suggest that diabetes and vascular disease are risk factors for 
HPU. However, this evidence comes from only one high quality study for 
diabetes and two high quality studies for lower limb vascular disease. 
The second high quality study to report on lower limb vascular disease 
as statistically significant [42] was a small explorative study and its 
analysis did not adjust for other potential risk factors. 
Physical conditions: age >65years, Braden subscales ‘moisture, 
friction and shear’, immobility/mobility (Braden and MNS subscales), 
nutritional status, perfusion issues, mechanical ventilation and surgery, 
all emerged as statistically significant in at least one high quality study. 
Age merged as an independent risk factor in only one high quality study 
[31]. Patients older than 65 years were more likely to develop HPUs 
compared to younger patients (OR: 3.3; 95%CI: 2.4–4.6). Malnu-
trition/impaired nutritional status was considered in two high quality 
studies [31,33],however, the two studies involved different study pop-
ulations (hospital inpatients and nursing/community care patients, 
respectively). Malnutrition only emerged as statistically significant in 
one of the two high quality studies [31], in this study, hospitalised pa-
tients suffering from malnutrition had an increased risk of developing 
HPUs by a factor of 6.9 (95%CI: 4.1–11.5). The Manderlier et al. (2019) 
[33] study was only aimed at examining what they considered ‘modi-
fiable patient-related risk factors’, defined as patient characteristics that 
are sensitive to interventions used by HCPs to prevent HPU develop-
ment’. Therefore, differences in study populations and variables exam-
ined could have contributed to some of the disparities between the 
Delmore et al. (2019) [31] and Manderlier et al. (2019) (33) study 
results. 
Perfusion issues, mechanical ventilation and surgery were examined 
in only one high quality study [31] involving hospitalised patients; all 
three variables emerged as highly significant (p-value< 0.001). Perfu-
sion issues were defined by the presence of conditions that affect blood 
to peripheral extremities - excluding vascular disease, which was 
considered separately. Patients that had evidence of perfusion issues (e. 
g., cardiovascular disease, myocardial infarction, hypovolemic shock) 
were at least 2.8 times more likely to develop HPUs compared to pa-
tients without perfusion issues. 
Participants on mechanical ventilation were at least seven times 
more likely to develop a HPU compared to those not on mechanical 
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Table 2 
Quality appraisal for individual studies (n = 11).  
















































valid and reliable 
measurement of 
outcome, method 








Clear definition of 
confounding 





and setting of 
confounding 
factors, Method 


















low   
Tourtual et 
al (1997) 
Low Low Moderate Moderate Moderate Moderate Moderate  1. Do not specify 
missing data  




on skin assessment  
3. Collect data on 
numerous factors 
however only used 
multivariable 
logistic regression 
in their validation 
study 2 to adjust for 
confounding factors  








analysis in study 2.  
6. Insufficient number 
of events- logistic 
regression analysis  
Demers 
(2005) 
Low Low High Moderate High High Low  1. Retrospective 
design-reviewing 
records  
2. Subjective nature of 
lack of quality 
assurance processes 
for risk factor 
measurement.  
3. Subjective nature of 
staging tool and 
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Table 2 (continued ) 















Details of Concerns  
2. Not specify number 
eligible or 
withdrawals.  
3. Subjective nature of 
staging tool and 




4. Only provide 
overall mean age for 
study population.  
5. Lack of reporting on 
missing data and 
reasons.  
6. High levels of 
missing data on 
reported risk factors 
also do not report 
for 2 other risk 
factors.  
7. Not specified 




Low Low Medium Medium High High   1. Retrospective 
design reviewing 
medical records.  
2. No clear eligibility 
criteria.  
3. Lack of validation of 
outcome measure  
4. Inadequate 
reporting of results 
as a result unable to 
clearly follow 
results extract 
appropriate data.  





















provided to assess 
generalisability of 
studies.  





4. Partial reporting of 
statistical analysis 
used.  
5. No effect size, 
confidence interval 
reported.  
Clegg et al 
(2009) 
Moderate Low Low Moderate High High Low  1. No adequate 
information on how 
subjects were 
(continued on next page) 
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Table 2 (continued ) 















Details of Concerns 
recruited or 
exclusion criteria.  





outcome measure as 
based on clinical 
staff assessment of 
skin assessment.  
4. Lacks comparator 
group.  




Moderate Low Low Moderate Moderate Moderate Moderate  1. Does not specify 
total number of 
patients screened 
and excluded for 
generalisability 
purposes.  




staging criteria).  
3. Lack of clear 
definition of risk 
factors and how 
these were 
measured.  
4. Partial reporting 
only p-values with 







Moderate Low Low Moderate Moderate High Moderate  1. Partial reporting 
study participation 
unable to fully 
assess 
representation.  




staging criteria).  
3. Descriptive analysis 
no adjusting for 
confounders.  
4. Conclusions are not 
based on reported 
results or research 
question.  








however do not 
provide full details.  
Delmore et 
al (2015) 
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Table 2 (continued ) 















Details of Concerns  
3. No specific 
exclusion criteria 
besides age for 
control group 
mentioned  






inclusion criteria).  
5. High risk of 
selection bias as 
authors don’t report 
final no. of reviewed 
records especially 
controls.  
6. Lack of reporting 
missing data and 
methods of 
imputation.  
7. No clear 
prespecified sample 
size calculation.  
8. Insufficient number 
of events- logistic 




Moderate High Moderate Moderate Moderate Moderate Moderate  1. Partial reporting on 
key characteristics 
however reported in 
RCT paper.  
2. Unable to assess risk 
of attrition bias due 
to lack of reporting.  
3. Unable to ascertain 
level of RF data 
collection due to 
inconsistencies in 
reporting (not clear 
how many patients 
had complete data 
for each RF.  
4. Lack of validation of 
outcome measure.  
5. Lack of reporting for 
confounders (pre- 
specifying RF vs 
confounders) at 
each follow-up time 
point.  
6. Selective reporting 
of significant data 
only  
7. Do not report risk 







Low Low Low Low Moderate Moderate High  1. No cofounding 
factors investigated 
or reported however 
authors 
acknowledge as 
limitation of study.  




Low Low Low Low Low Low High  1 Lack of validation of 
outcome measure  
Low Low Low Low Low Low High 
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ventilation (OR: 7.7; 95%CI:4.2–14.3; p-value <0.001) [31]. Partici-
pants who had surgery during their hospital stay had an increased risk of 
developing a HPU by a factor of 1.8 (95%CI: 1.3–2.5) compared to those 
who did not have surgery [31]. Types of surgery reported were divided 
into seven categories: vascular, orthopaedic, neurosurgery, intestinal, 
cardiovascular, and genitourinary and gynaecology. Cardiovascular 
surgery was the most common amongst those that developed HPU, ac-
counting for 27.9% of all surgeries. 
Mobility/immobility was considered in one high quality [33] and 
three moderate quality studies [29,30,32]. Manderlier et al. (2019) [33] 
defined mobility using the Braden subscale. In Delmore et al. (2015) 
[30] (moderate quality), immobility was associated with health condi-
tions that impaired the ability to mobilise, for example, plegia, cardio-
vascular accidents, lower extremity fractures, and orthopaedic 
surgeries; whereas Muntlin-Athlin et al. (2016) [32] (moderate quality 
study) utilised the MNS subscale ‘mobility’ to measure patients’ ability 
to move independently. Although mobility/immobility was measured 
differently across the four eligible studies, it emerged as statistically 
significant in all four studies. Based on the results of a high quality study, 
an increase in the mobility score (as measured using the Braden subscale 
‘mobility’), reduced the likelihood of developing a HPU (0.6; 95% CI: 
0.4–0.8) [33]. 
The Braden subscale ‘friction/shear’ emerged as statistically signif-
icant in one high quality study [33] and one moderate quality [29]. An 
increase in the friction and shear score decreased the likelihood of 
developing a HPU (0.3; 95% CI 0.2–0.5) [33]. 
Moisture (as measured using the Braden subscale ‘moisture’ or MNS 
subscale ‘incontinence’), only emerged as statistically significant in one 
moderate quality study each [29,32] respectively. However, the Braden 
subscale ‘moisture’ did not emerge as statistically significant in a high 
quality study [33]. Further high quality studies are required to investi-
gate the impact of the identified potential risk factors in the wider pa-
tient population, in order to increase the generalisability of results and 
inform future practice. 
5. Discussion 
This is the first systematic literature review of observational studies 
investigating risk factors for developing HPUs. As evident from this re-
view, there are too few studies focusing on this area, despite HPUs being 
the second most common type of PU. Understanding the biology and 
natural history of HPUs is paramount in order to optimise prevention 
strategies. Risk factors can be barriers to healing, and in worse case 
scenarios, they can instigate life threatening outcomes if they are not 
addressed and corrected in a timely manner. Evidence based prevention 
strategies, including educational programs, empower both patients and 
their carers to manage their risk - especially outside of care settings. 
Most of the studies reviewed provided descriptive results or uni-
variate analysis, which did not adjust for other potential risk factors or 
consider the impact of living with several comorbidities to their study 
population. There was also evidence of selective reporting, as studies 
mostly reported statistically significant results. The problematic use of 
less robust designs and analytical techniques has previously been 
highlighted by Clegg and Palfreyman (2014) [24] in their review on 
elevation devices used to prevent HPUs. These have also been common 
themes in this review - with serious implications on the quality and 
generalisability of specific study results. It was also evident that many of 
the studies did not follow STROBE recommendations, which made it 
difficult to synthesise the evidence. Despite observational studies often 
being criticised for their vulnerability to being influenced by unknown 
confounding factors, well-designed observational studies can also com-
plement RCTs in hypothesis generation, defining clinical questions and 
establishing future research questions [43,44]. The results of this review 
can therefore be used to generate hypotheses for further research studies 
investigating risk factors for developing HPUs. 
Only three (27.2%) eligible studies were rated high quality [31,33, 
42]. Their study populations and research questions were different, 
which may have contributed to a difference in the risk factors that 
emerged as statistically significant. In total, the review identified 16 risk 
factor domains, however due to the small number of eligible studies, this 
meant that each potential risk factor was evaluated in three or less 
studies of high to moderate quality. In light of this review, it is not 
surprising that current clinical practice recommendations and guidance 
do not provide substantial specific guidance on risk assessment and 
prevention of HPUs [8,45]. It is therefore imperative that future 
research addresses these limitations and focuses on risk factors for HPUs 
in order to reduce their prevalence and incidence rates. 
In this review, HPU incidence and prevalence rates were estimated as 
17.4% (2.9–29.5%) and 11.7% (1.5–20.8%) respectively; however, the 
actual rates remain unclear due to heterogeneity of study populations, 
designs and quality of the studies. for instance, in this review involved 
retrospective review of medical notes, or they lacked quality assurance 
processes for their outcome measure, this affected studies that used skin 
assessments to diagnose HPUs. Diagnosis of HPUs remains a challenge in 
practice due to the misclassification of wounds affecting lower limbs; 
that is, many clinicians lack the ability to distinguish between diabetic 
foot ulcers, vascular related ulcers and PUs [20]. For retrospective 
studies included in this review, this could potentially have contributed 
to an under or overestimation of HPUs due to lack of documentation or 
misclassification of HPUs by clinical staff. 
HPUs, like any other PU, have multifactorial contributory factors 
[21]. However, the actual risk factors associated with HPU development 
may be different due to the anatomy and anatomical position of the heel 
in the body, as suggested in biomechanical and other studies [18–20]. 
This review found that age >65 years, diabetes, malnutrition, surgery, 
mechanical ventilation, perfusion issues, vascular disease [31] and 
Braden subscales ‘friction and shear’, ‘mobility’ [33] emerged as sig-
nificant risk factors in the presence of other variables using multivari-
able analysis from two high quality studies. These results are consistent 
with the aetiology of HPUs [3]. Braden subscales ‘friction and shear’, 
and ‘mobility’ only explained 16.6% of the variance in the prevalence of 
HPUs amongst nursing home patients or those receiving community care 
[33]. Delmore and colleagues were able to correctly identify 74% of 
their validation sample as either with or without HPUs using their 
regression model, which included: vascular disease, diabetes, malnu-
trition, surgery, mechanical ventilation and perfusion issues [31]. It is 
evident from the results of the two separate final regression models by 
Delmore et al. (2019) [31] and Manderlier et al. (2019) (33), that other 
contributory factors exist that were not explored in either study. 
Although both studies were the two largest, they involved different 
population samples. 
The Braden scale has six subscales (sensory perception, moisture, 
mobility, activity, nutrition and friction and shear) and was the most 
used risk assessment tool (RAT) in the eligible studies. Subscales ‘friction 
Table 2 (continued ) 



















1 Lack of validation of 
outcome measure  
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Table 3 
Summary of strength of evidence for identified risk factors (n = 11).  
Risk factor High quality studies Moderate quality studies Low quality studies 
Patient Characteristics 
Age Delmore et al. (2019) Tourtual et al. (1997); Campbell et al. 
(2010)  
Height  Tourtual et al. (1997) Clegg et al. (2009) 
Weight (initial, final)  Tourtual et al. (1997) Clegg et al. (2009) 
BMI   Clegg et al. (2009) 
Smoker   Clegg et al. (2009) 
Vital signs 
Heart rate (highest)  Tourtual et al. (1997); Campbell et al. 
(2010); Muntlin-Athlin et al. (2016) 
Clegg et al. (2009) 
Pulse oximetry  Muntlin-Athlin et al. (2016) Clegg et al. (2009) 
Respiratory rate  Muntlin-Athlin et al. (2016)  
Blood pressure (systolic, diastolic)  Muntlin-Athlin et al. (2016) Duncan et al. 
(2003)  
Hypotension  Duncan et al. (2003)  
Reaction level scale  Muntlin-Athlin et al. (2016)  
Haematological measures 
Albumin (initial; final)  Tourtual et al. (1997) Clegg et al. (2009) 
Pre-albumin   Clegg et al. (2009) 
Blood Urea   Clegg et al. (2009) 
Creatinine   Clegg et al. (2009) 
Protein- Initial  Tourtual et al. (1997)  
Haemoglobin (g/L) (initial)  Tourtual et al. (1997)  
Skin Status 
Admitted with PU  Tourtual et al. (1997)  
Moisture/incontinence 
Incontinence; Braden subscale-Moisture; MNS subscale Incontinence Manderlier et al. (2019) Tourtual et al. (1997); Muntlin-Athlin et al. 
(2016)  
Preventive measures for HPU 
Preventative ointment on heels on admission  Tourtual et al. (1997)  
Sheets tightly tucked in before development of HPU  Tourtual et al. (1997)  
HPU relief measures used  Tourtual et al. (1997)  
Disease or physical conditions 
Total number of diagnosis  Tourtual et al. (1997)  
Had a diagnosis of neoplasm  Tourtual et al. (1997); Gaubert-Dahan et al. 
(2013)  
Systemic infection   Clegg et al. (2009) 
Limb weakness (left/right/both)  Tourtual et al. (1997)  
Diabetes Delmore et al. (2019) Gaubert-Dahan (2013); Delmore et al. 
(2015) 
Clegg et al. (2009) 
Perfusion issues defined congestive heart failure, MI, anaemia, 
dehydration, pedal oedema 
Delmore et al. (2019) Tourtual et al. (1997) Clegg et al. (2009) 
Circulatory problems of lower limb  Tourtual et al. (1997) Clegg et al. (2009) 
peripheral arterial disease/vascular disease Twilley and Jones (2016); 
Delmore et al. (2019) 
Meaume and Faucher (2007); Delmore et al. 
(2015); 
Clegg et al. (2009) 
venous stasis disease   Clegg et al. (2009) 
Pulses (not palpable on one or the other extremity):    
Popliteal/Posterior Tibia  Tourtual et al. (1997) Clegg et al. (2009) 
Respiratory disease  Tourtual et al. (1997); Campbell et al. 
(2010)  
End-stage renal Disease   Clegg et al. (2009) 
Nutritional Status 
Any 3-consecutive worsening of appetite/Nutrition services 
documented  
Tourtual et al. (1997)  
Nutrition-Braden subscale/Malnutrition/impaired nutrition Delmore et al. (2019); 
Manderlier et al. (2019)   
Length of stay (LOS)  Tourtual et al. (1997); Campbell et al. 
(2010)  
Sensory perception 
Braden subscale-Sensory perception;  Tourtual et al. (1997)  
Sensory peripheral neuropathy (NSS, NDS)  Gaubert-Dahan et al. (2013); Delmore et al. 
(2019)  
Friction and shear 
Braden subscale-Friction and shear Manderlier et al. (2019) Tourtual et al. (1997)  
Mobility/Physical activity 
Activity- Braden subscale/MNS subscale  Tourtual et al. (1997); Delmore et al. 
(2015); Muntlin-Athlin et al. (2016)  
Mobility- Braden subscale/MNS subscale/Immobility Manderlier et al. (2019) Tourtual et al. (1997); Delmore et al. 
(2015); Muntlin-Athlin et al. (2016)  
Risk Assessment tools 
Braden Scale total risk score  Tourtual et al. (1997); Delmore et al. (2015) Demers (2005) 
MNS total risk score  Muntlin-Athlin et al. (2016)  
Pre and post-operative risk assessments  Duncan et al. (2003)  
Medication 
(continued on next page) 
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and shear’ and ‘mobility’ or a Braden scale ‘total score ≤18’ emerged as 
significant in high to moderate quality studies. The MNS was the only 
other RAT to be considered by one moderate quality study included in 
this review. RATs are key to PU prevention, as recommended in both 
national and international guidelines [3,45,46]. In clinical practice 
there are numerous other validated RATs (for example Waterlow, 
Ramstadius, and PURPOSE T) available for use, and it is up to clinicians 
and their employers to decide upon which one to use. Although using 
validated RATs is recommended, they have also been criticised in the 
literature for their inability to reduce PUs and have been found to be 
inferior compared to clinical judgement [47,48]. A possible explanation 
for their poor performance may include how RATs are implemented in 
practice. Clinicians may perhaps focus on the final risk score, rather than 
the individual’s risk profile, as identified by the RAT. 
Mental status is another potential risk factor that needs further 
investigation given that one in three older people are living with some 
form of cognitive impairment (e.g., dementia, Alzheimer’s or severe 
Parkinson’s disease), and more than half have severe dementia [49]. 
These conditions are likely to affect individuals’ concordance with HPU 
preventive strategies. Current national and international guidelines [8, 
45] recommend offloading both heels to prevent and treat HPUs. Where 
there are concordance issues, this strategy may be inadequate, and cli-
nicians must use their clinical judgement on which device to use. 
Perioperative analgesia (neuraxial blocks or peripheral nerve blocks; 
PNB) and sensory neuropathy were also considered as potential risk 
factors for HPU development. Patients exposed to these types of anal-
gesia/anaesthesia are more likely to develop HPUs due to the temporary 
loss of mobility and peripheral sensation. For example, in pregnant 
women (although the incidence is rare [50,51]), and older patients the 
risk of developing HPU is likely to increase whilst the perioperative 
analgesia is still effective. Regrettably, there is a paucity of high quality 
evidence to support whether perioperative analgesia or sensory neu-
ropathy contribute to HPU development, and therefore would require 
further elucidation. 
5.1. Strength and limitations 
This study has several limitations. Generalisations and inference 
require caution as the included studies were mostly rated as moderate 
quality, due to poor study designs, analysis, and reporting. Risk factors 
identified as independent predictors of HPUs were only examined in one 
high quality study [31,33]. Clinical and statistical heterogeneity of 
studies and poor reporting standards affected the ability to quantita-
tively synthesis any extracted data. A strength of this review is that it 
incorporated a quality assurance phase, involving a further risk of bias 
and quality assessment of a random selection of 50% of eligible studies 
by an independent third reviewer. 
Finally, at least 60.0% of all reported HPUs in the eligible studies 
were either category 1 or 2. Only one study investigated risk factors 
associated with category 3 or 4. Therefore, it could be argued that the 
risk factors investigated or identified in this review were associated with 
the development of superficial HPUs. More severe HPUs are likely to 
have different aetiology. Furthermore, due to poor reporting and the 
lack of conclusive evidence, the review was not able to fully quantify the 
relationship between risk factors and HPU development. More people 
are living longer with multiple comorbidities, including those affected 
by cognitive impairment. It is imperative that future research studies 
focus on investigating risk factors, incidence, and prevalence rate for 
HPUs. This will help ascertain whether current HPU preventative mea-
sures are fit for purpose. 
5.2. Implications for practice and future research  
• Heel remain the second most common site for developing pressure 
ulcers, with an estimated incidence rate of at least 17% and 11% 
prevalence rate. The results of this review suggest that current HPU 
preventative interventions may require further improvement in 
order to reduce the incidence rates. 
Table 3 (continued ) 
Risk factor High quality studies Moderate quality studies Low quality studies 
Vasopressor use   Clegg et al. (2009); 
Corticosteroid use   Clegg et al. (2009); 
Epidural (level of epidural, concentration of local anaesthesia)  Duncan et al. (2003) Edward et al. (2006) 
Surgery 
Length of surgery  Delmore et al. (2015) Clegg et al. (2009) 
Type of surgery (vascular, orthopaedic, neurosurgery, intestinal, 
cardiovascular, genitourinary, gynaecology,TKR,THR) 
Delmore et al. (2019) Campbell et al. (2010) Clegg et al. (2009); 
Edward et al. (2006) 
Mechanical ventilation Delmore et al. (2019)   
All variables are reported in the table using the same descriptions as in the original articles. TKR-total knee replacement; THR-total hip replacement. 
Table 4 
Examples of database search strategies.  
Database Search Terms 
CINAHL (MH “Heel Ulcer/EP/ET/PC”); TI heel ulcer* OR AB heel 
ulcer*; TI (risk factors or contributing factors or predisposing 
factors) 
Cochrane Library MeSH descriptor: [Heel] explode all trees; MeSH descriptor: 
[Pressure Ulcer] explode all trees; MeSH descriptor: [Risk 
Factors] explode all trees 
EMBASE heel.sh. or heel*.ab. or heel*.ti.; pressure ulcer.sh. or pressure 
ulcer*.ab. or pressure ulcer*.ti.; limit 11 to (human and (adult 
<18–64 years > or aged <65+ years>)) 
MEDLINE MH heel; TI heel OR AB heel; MH pressure ulcer; (MH “Skin 




Heel pressure ulcer 
PROQUEST 
Database 
(su(pressure ulcer*) OR ti(pressure ulcer*) OR ab(pressure 
ulcer*) OR su(bedsore*) OR ti(bedsore*) OR ab(bedsore*) OR 
su(pressure injur*) OR ti(pressure injur*) OR ab(pressure 
injur*) OR su(decubitus) OR ti (decubitus) OR ab (decubitus)) 
AND (su(heel*) OR ti(heel*) OR ab(heel*)) AND (su(risk*) 
OR ti(risk*) OR ab(risk*)) 
PubMed (((pressure injur*[Title/Abstract]) AND heel[Title/ 
Abstract])) OR (((((((pressure ulcer*[MeSH Terms]) AND 
heel[MeSH Terms])) OR ((pressure ulcer*[Title/Abstract]) 
AND heel[Title/Abstract])) OR ((bedsore*[Title/Abstract]) 
AND heel[Title/Abstract])) OR ((decubitus ulcer[MeSH 
Terms]) AND heel[MeSH Terms])) OR ((decubitus ulcer 
[Title/Abstract]) AND heel[Title/Abstract])) 
Scopus (TITLE-ABS-KEY ( “heel pressure ulcer”) OR TITLE-ABS-KEY 
(“heel pressure sore”) OR TITLE-ABS-KEY (“heel pressure 
injury”) OR TITLE-ABS-KEY (heel W/3 bedsore) OR TITLE- 
ABS-KEY (heel W/3 decubitus) AND TITLE-ABS-KEY (risk 
AND factors) ) 
Trip PRO Pressure injur* heel; (decubitus heel); (bed sore heel); 
(pressure sore heel); (pressure ulcer heel) 
Web of Science 
Database 
TITLE: (pressure ulcer*) OR TOPIC: (pressure ulcer*) OR 
TOPIC: (pressure injur*) OR TITLE: (pressure injur*) OR 
TOPIC: (bedsore*) OR TITLE: (bedsore*) OR TOPIC: (pressure 
sore*) OR TITLE: (pressure sore*) OR TOPIC: (decubitus) OR 
TITLE: (decubitus) 
Indexes = SCI-EXPANDED, SSCI, A&HCI, CPCI–S, CPCI-SSH, 
ESCI Timespan = All years  
A. Dube et al.                                                                                                                                                                                                                                    
Journal of Tissue Viability xxx (xxxx) xxx
19
• Several potential risk factors for developing HPU have been identi-
fied in this review however only 3 studies were of high quality and 
involved heterogenous populations. Therefore, due to paucity of 
high quality evidence, clinicians should continue using their clinical 
judgement whilst reacting to individual patients’ risk when evalu-
ating and implementing HPU prevention strategies.  
• This is the first systematic literature review of risk factors associated 
with development of HPUs, there is lack of high quality studies to 
inform evidence based practise. Therefore, further research is 
required to inform clinical practice and reduce harm. 
6. Conclusions 
This is the first systematic review of observational studies investi-
gating risk factors for HPUs. There is a paucity of high quality evidence 
on risk factors for developing HPUs, despite being the second most 
common type of PU. Age, Braden subscales ‘friction and shear’ and 
‘mobility’, diabetes, vascular disease, malnutrition, mechanical venti-
lation, perfusion issues and surgery were identified as potential risk 
factors, after adjusting for other factors. However, further research is 
required to elucidate these risk factors in addition to well-designed 
studies to increase the body of evidence. Other risk factors related 
HPU development may also exist - including age, BMI, haematological 
measures, comorbidities, and smoking status, which requires further 
investigation. 
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